JNJ-86974680

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JNJ-86974680, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer [Phase 1]